Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shepherd

Showing results (391-400 of 452) with videos related to

Pageof 46
Sort By:
European Journal of Haematology|November 15, 2002
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)M D Seftel, H Bruyere, M Copland, et al.
Frontiers in Plant Science|August 1, 2022
Systematics and Plastome Evolution in SchizaeaceaeBing-Feng Ke, Goang-Jiun Wang, Paulo H Labiak, et al.
Current Biology : CB|August 9, 2025
dArc1 controls sugar reward valuation in Drosophila melanogasterSven Bervoets, Miles Solomon Jacob, Anita V Devineni, et al.
Journal of Hematotherapy & Stem Cell Research|July 14, 2000
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulinK G McCaul, T J Nevill, M J Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Shifting to outpatient management of acute myeloid leukemia: a prospective experienceM L Savoie, T J Nevil, K W Song, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
<i>dArc1</i> controls sugar reward valuation in <i>Drosophila melanogaster</i>Sven Bervoets, Miles Solomon Jacob, Anita V Devineni, et al.
Leukemia & Lymphoma|June 28, 2016
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphomaAlden A Moccia, Felicitas Hitz, Paul Hoskins, et al.
Leukemia & Lymphoma|July 1, 1997
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blastsB I Dalal, V Wu, M J Barnett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2004
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)Haytham Khoury, Bakul I Dalal, Stephen H Nantel, et al.
Neuron|July 11, 2008
Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTDSungjin Park, Joo Min Park, Sangmok Kim, et al.
Pageof 46

Showing results (391-400 of 452) with videos related to

Sort By:
Pageof 46
European Journal of Haematology|November 15, 2002
Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22)M D Seftel, H Bruyere, M Copland, et al.
Frontiers in Plant Science|August 1, 2022
Systematics and Plastome Evolution in SchizaeaceaeBing-Feng Ke, Goang-Jiun Wang, Paulo H Labiak, et al.
Current Biology : CB|August 9, 2025
dArc1 controls sugar reward valuation in Drosophila melanogasterSven Bervoets, Miles Solomon Jacob, Anita V Devineni, et al.
Journal of Hematotherapy & Stem Cell Research|July 14, 2000
Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulinK G McCaul, T J Nevill, M J Barnett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2006
Shifting to outpatient management of acute myeloid leukemia: a prospective experienceM L Savoie, T J Nevil, K W Song, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
<i>dArc1</i> controls sugar reward valuation in <i>Drosophila melanogaster</i>Sven Bervoets, Miles Solomon Jacob, Anita V Devineni, et al.
Leukemia & Lymphoma|June 28, 2016
Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphomaAlden A Moccia, Felicitas Hitz, Paul Hoskins, et al.
Leukemia & Lymphoma|July 1, 1997
Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blastsB I Dalal, V Wu, M J Barnett, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2004
Correlation between karyotype and quantitative immunophenotype in acute myelogenous leukemia with t(8;21)Haytham Khoury, Bakul I Dalal, Stephen H Nantel, et al.
Neuron|July 11, 2008
Elongation factor 2 and fragile X mental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTDSungjin Park, Joo Min Park, Sangmok Kim, et al.
Pageof 46